Regencell Bioscience Holdings stock has a qualified bullish daily bias, but the shorter timeframes do not offer unanimous confirmation. The daily close stands above the shorter exponential averages and upper Bollinger band, while remaining below the 200-session EMA. Meanwhile, the hourly structure supports the bullish case, but the 15-minute readings complicate near-term timing.
RGC — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
RGC closed at $9.52 on Thursday, October 15, 2026, gaining 17.39% with volume of 1,911,000 shares.
Daily RSI14 stands at 77.79 , in overbought territory, while daily MACD remains above its signal.
The close is above the 20-session EMA at $7.17 and 50-session EMA at $7.18, but below the 200-session EMA at $13.27.
Hourly RSI14 is 60.32, above 50, and hourly MACD remains above its signal.
For the next session, the daily pivot is $9.45 , with first resistance at $11.19 and first support at $7.79.
On Thursday, October 15, 2026, RGC opened at $7.98. The session ranged from a low of $7.72 to a high of $11.12, and closed at $9.52 . The gain was 17.39% versus the previous close, with session volume of 1,911,000 shares. A search of recent coverage found no company-specific news. RGC opened at $7.98, traded between a low of $7.72 and a high of $11.12, and closed at $9.52, against a previous close of $8.11.
Regencell Bioscience Holdings Stock: The Daily Case Remains Conditional
The daily case for Regencell Bioscience Holdings stock is bullish but conditional. The close sits above the 20-session EMA at $7.17 and the 50-session EMA at $7.18. However, the 20-session average remains below the 50-session average, and the 200-session EMA stands overhead at $13.27 . This is not a fully aligned bullish daily trend.
Daily RSI14 stands at 77.79 , in overbought territory. The daily MACD line is 0.63, above its signal at 0.38, with a positive histogram of 0.24. These readings support the bullish bias, although the RSI makes overbought conditions an important qualification.
Notably, the $9.52 close is above the daily upper Bollinger band at $8.75 . The mid-band sits at $6.88 and the lower band at $5.01. This places price beyond the upper boundary rather than within the bands. Daily ATR14 rose to $0.89 from $0.69, indicating greater measured volatility than in the preceding daily candle.
Hourly Confirmation and Short-Term Conflict
Hourly RGC Structure Aligns With the Daily Bias
Hourly averages are bullishly aligned beneath the session close. The 20-hour EMA is $8.75, above the 50-hour EMA at $8.04 and the 200-hour EMA at $6.84. Price also sits between the hourly Bollinger mid-band at $8.62 and upper band at $10.24 .
However, hourly RSI14 fell to 60.32 from 65.86, while remaining above 50. The hourly MACD histogram declined to 0.16 from 0.21. Its line remains above its signal, at 0.58 versus 0.42. So the hourly evidence still supports the daily bias despite those declines.
15-Minute Chart Complicates Near-Term Timing
In contrast, the 15-minute chart presents less supportive execution conditions. The close is below the 20-period EMA at $9.71 but above the 50-period EMA at $9.08. RSI14 is 48.28, below 50, while the MACD line at 0.34 is below its signal at 0.47. The negative histogram of -0.13 reinforces that short-term conflict without overriding the daily view.
Next-Session Levels and Conditional Scenarios
Bullish Scenario Requires Clearing Short-Term Pivots
For the next session, the daily pivot sits at $9.45 . First resistance is at $11.19 and first support at $7.79. These levels apply when trading resumes. The hourly pivot for the next session is $9.56, while the 15-minute pivot is $9.53. Both shorter-timeframe pivots sit just above the session close.
The bullish scenario requires holding the daily pivot at $9.45. It then needs to clear the 15-minute pivot at $9.53, then the hourly pivot at $9.56. A move above the 15-minute 20-period EMA at $9.71 would add short-term confirmation. Beyond that, the hourly upper Bollinger band at $10.24 precedes the session high at $11.12. Daily first resistance sits at $11.19.
Bearish Conditions and Support Levels Below
Conversely, a break below $9.45 would weaken the immediate bullish setup. The 15-minute 50-period EMA at $9.08 and daily upper Bollinger band at $8.75 would then serve as lower reference levels. Failure to hold daily first support at $7.79 would invalidate the immediate bullish case. The daily shorter averages would then sit below that level.
Overall, Regencell Bioscience Holdings stock stands above the daily pivot but below both shorter-timeframe pivots for the next session. Daily ATR14 at $0.89 underscores the volatility context. The unresolved issue is whether short-term conditions can support the bullish daily bias while daily RSI remains overbought.
FAQ
Where did RGC close on Thursday, October 15, 2026?
RGC closed at $9.52, up 17.39% from the previous close, with session volume of 1,911,000 shares.
What are the key levels for the next session?
The daily pivot is $9.45, with first resistance at $11.19 and first support at $7.79. The hourly pivot is $9.56 and the 15-minute pivot is $9.53.
What does the daily RSI reading indicate?
Daily RSI14 stands at 77.79, placing it in overbought territory, while the daily MACD remains above its signal.
{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”Where did RGC close on Thursday, October 15, 2026?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”RGC closed at $9.52, up 17.39% from the previous close, with session volume of 1,911,000 shares.”}},{“@type”:”Question”,”name”:”What are the key levels for the next session?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The daily pivot is $9.45, with first resistance at $11.19 and first support at $7.79. The hourly pivot is $9.56 and the 15-minute pivot is $9.53.”}},{“@type”:”Question”,”name”:”What does the daily RSI reading indicate?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Daily RSI14 stands at 77.79, placing it in overbought territory, while the daily MACD remains above its signal.”}}]}
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
